5-hydroxy-1-methyl-2-(2,2,2-trifluoro-1-hydroxy-ethyl)-1H-pyridin-4-one | 1064077-53-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 5-hydroxy-1-methyl-2-(2,2,2-trifluoro-1-hydroxy-ethyl)-1H-pyridin-4-one
• 英文别名: 5-hydroxy-1-methyl-2-(2,2,2-trifluoro-1-hydroxyethyl)pyridin-4(1H)-one；5-hydroxy-1-methyl-2-(2,2,2-trifluoro-1-hydroxyethyl)pyridin-4-one
• CAS: 1064077-53-7
• 化学式: C₈H₈F₃NO₃
• 分子量: 223.152
• InChiKey: YOTDQSWZBFGAPQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  60.8
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  5-hydroxy-1-methyl-2-(2,2,2-trifluoro-1-hydroxy-ethyl)-1H-pyridin-4-one 在 氯化亚砜 作用下， 以 水 、 乙腈 为溶剂， 生成 2-(dimethylamino)-3-hydroxy-1-methyl-6-(2,2,2-trifluoroethyl)pyridin-4(1H)-one
  参考文献：
  名称：

  [EN] FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES
  [FR] DÉRIVÉS FLUORÉS DE 3-HYDROXYPYRIDIN-4-ONES

  摘要：

  提供的是Formula I的化合物，它们是3-羟基吡啶-4-酮的衍生物。这些化合物可用于治疗与铁的毒性浓度有关的医疗状况。这些化合物可用于制备用于治疗与铁的毒性浓度有关的医疗状况的药物。与铁的毒性浓度有关的医疗状况可从以下组中选择：癌症、肺部疾病、进行性肾病和弗里德里希共济失调。

  公开号：

  WO2011000104A1
• 作为产物：
  描述：

  5-(benzyloxy)-1-methyl-2-(2,2,2-trifluoro-1-hydroxyethyl)pyridin-4(1H)-one 在 钯 盐酸 作用下， 以 甲醇 为溶剂， 反应 0.67h， 以to give 5-hydroxy-1-methyl-2-(2,2,2-trifluoro-1-hydroxy-ethyl)-1H-pyridin-4-one as a solid product (2.05 g, 92% yield, HPLC Method 1 (Example 24), RT=7.4 min, HPLC purity (peak percent area): 99.4% at λ=280 nm)的产率得到5-hydroxy-1-methyl-2-(2,2,2-trifluoro-1-hydroxy-ethyl)-1H-pyridin-4-one
  参考文献：
  名称：

  Fluorinated derivatives of deferiprone

  摘要：

  本发明涉及deferiprone的新衍生物。特别是，本发明涉及氟代的deferiprone衍生物或其药学上可接受的盐，包括同样的制药组合物，其制造过程以及它们在治疗由于神经组织中存在游离铁或铁积累引起的神经退行性疾病和需要去除或重新分配过量铁的疾病中的用途。

  公开号：

  US08026261B2

文献信息

• FLUORINATED DERIVATES OF 3-HYDROXYPYRIDIN-4-ONES
  申请人：Tam Tim Fat

  公开号：US20120270882A1

  公开（公告）日：2012-10-25

  Provided are compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Frederich's Ataxia.

  提供的是公式I的化合物，它们是3-羟基吡啶-4-酮的衍生物。这些化合物可以用于治疗与铁的毒性浓度相关的医疗状况。这些化合物可以用于制备治疗与铁的毒性浓度相关的医疗状况的药物。与铁的毒性浓度相关的医疗状况可以从以下组中选择：癌症、肺部疾病、进行性肾脏疾病和弗里德里希共济失调症。
• Fluorinated Derivatives of Deferiprone
  申请人：Tam Tim Fat

  公开号：US20120095061A1

  公开（公告）日：2012-04-19

  The present invention relates to novel derivatives of deferiprone. In particular, the present invention relates to fluorinated derivatives of deferiprone or pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising same, processes for the manufacture thereof and their use in the treatment of neurodegenerative diseases caused by the presence of free iron or iron accumulation in neural tissues and in diseases wherein excess iron must be removed or redistributed.

  本发明涉及新型去铁酮衍生物。特别地，本发明涉及氟化去铁酮衍生物或其药学上可接受的盐、包含其的制药组合物、其制造过程以及在治疗由自由铁或神经组织中铁积累引起的神经退行性疾病和需要去除或重新分配过量铁的疾病中的应用。
• FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES
  申请人：APOTEX TECHNOLOGIES INC.

  公开号：US20150335626A1

  公开（公告）日：2015-11-26

  Provided are compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Frederich's Ataxia.

  提供的是I式化合物，它们是3-羟基吡啶-4-酮的衍生物。这些化合物可用于治疗与铁的毒性浓度相关的医疗状况。这些化合物可用于制备治疗与铁的毒性浓度相关的医疗状况的药物。与铁的毒性浓度相关的医疗状况可从以下组中选择：癌症，肺部疾病，进行性肾脏疾病和弗里德里希共济失调症。
• Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones
  申请人：Apotex Technologies Inc.

  公开号：US20160083346A1

  公开（公告）日：2016-03-24

  Compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Friedreich's ataxia.

  公式I的衍生物化合物是3-羟基吡啶-4-酮的衍生物。这些化合物可用于治疗与铁的毒性浓度相关的医疗状况。这些化合物可用于制备治疗与铁的毒性浓度相关的医疗状况的药物。与铁毒性浓度相关的医疗状况可以从以下组中选择：癌症、肺病、进行性肾病和弗里德赫氏共济失调。
• FLUORINATED DERIVATIVES OF DEFERIPRONE
  申请人：Apotex Technologies Inc.

  公开号：EP2134688B1

  公开（公告）日：2016-10-05